No Data
Rating information (Target Price change - Part 1) = Yokogawa HD, UPR ETC
◎Nomura Securities (three-tier rating: Buy > neutral > Reduce) Yokogawa HD <5911.T> --- "neutral" → "neutral", 2990 yen → 2900 yen Minebea M <6479.T> --- "neutral" → "neutral", 3100 yen → 3000 yen Makita <6586.T> --- "neutral" → "neutral", 5000 yen → 6000 yen Mabuchi <6592.T> --- "neutral" → "neutral", 2510 yen → 2450 yen Hi.
Stocks that moved the day before part 2: Liberata, Kyuso Distribution System, BTM, etc.
Stock name <Code> 10-day closing price ⇒ Compared to the previous day PeptiDream <4587> 2347.5 -691, breaking through the November low, selling pressure from short positions is dominant. Kewpie <2809> 3100 -123, Q4 results and this fiscal year's guidance are below market expectations. Onward HD <8016> 588 -14, viewing the cumulative operating profit for Q3 as a negative due to a double-digit decrease. T&D HD <8795> 2794.5 -711, on the 10th, sell-offs concentrated on financial-related stocks. Chugai Pharmaceutical <4519>
Spot information on individual stocks (2)
Warabeya Nichiyo <2918.T> rebounds after four days. The consolidated operating profit for the third quarter cumulative of the fiscal year ending in February (last year's March to November) saw a slight decrease, but exceeded the full-year Financial Estimates. Open Work <5139.T> rebounds after three days. It is reported that they have started a social networking service called "Open Work Career" where information about job changes and work styles can be exchanged. Kiyuso Distribution <9369.T> continues to decline significantly. The consolidated operating profit estimate for the fiscal year ending in November is 5.6 billion yen (a 1% increase compared to the previous period).
Kiyuso Distribution and others continue to rank, with a significant forecast of reduced ordinary profits this term.
Kyuso Distribution <9369> has made the ranking (as of 13:32). There has been a significant continued decline. The previous day, the financial results for the fiscal year ending November 2024 were announced, with an ordinary profit of 4.89 billion yen, a 40.8% increase compared to the previous term, surpassing the previous Financial Estimates of 4.5 billion yen. On the other hand, for the fiscal year ending November 2025, an outlook of 3.7 billion yen, a 24.3% decrease, has been projected, which seems to lead to negative factors. There are expectations of stagnation in sales growth, along with significant deterioration in non-operating income and expenses. Volume change rate ranking [January 10]
<Individual Stock Trends> Saitori Cells, Yoshimura FH, Daiwa, Kiyuso Distribution, Sankyo Tateyama = 10 days before opening.
Saitori Cell <3750.T> - Shareholders who hold one unit (100 shares) or more as of the end of March each year, as recorded in the company's shareholder registry, will receive a QUO card worth 5,000 yen as a shareholder benefit. Yoshimura FH <2884.T> - Consolidated subsidiary Marukichi received a subsidy of 382 million yen from the Aquatic Products Stable Supply Promotion Organization for the "ALPS treated water emergency new demand development support project" as of the 9th. Daiwa <8247.T> - Cumulative results for the fiscal year ending February 25, third quarter (from March to November 24).
Volume change rate ranking (10 o'clock period) - Hisamitsu Pharmaceuticals, Sankyo Seiko, ETC are ranked.
In the volume change rate ranking, by comparing the average volume over the last five days with the volume on the day of distribution, it is possible to understand the trends in market participants' interests, etc. ■ Top volume change rates [As of January 10, 10:32] (Comparing the most recent five-day average volume) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <4530> Hisamitsu Pharmaceutical 933,000 403,072.06 255.26% 0.132% <7888> Sanko Gosei 9